| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1220 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1174 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 1028 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 892 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 735 | 2021 |
| SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022 | 564 | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 467 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 375 | 2021 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 270 | 2020 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... Science 374 (6566), 423-431, 2021 | 217 | 2021 |
| SimPhy : Phylogenomic Simulation of Gene, Locus, and Species Trees D Mallo, L de Oliveira Martins, D Posada Systematic biology 65 (2), 334-344, 2016 | 170 | 2016 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 135 | 2021 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ... Science 378 (6615), eabq5358, 2022 | 120 | 2022 |
| Nanoneedle-mediated stimulation of cell mechanotransduction machinery CS Hansel, SW Crowder, S Cooper, S Gopal, M João Pardelha da Cruz, ... ACS nano 13 (3), 2913-2926, 2019 | 120 | 2019 |
| Evolutionary Process of Deep-Sea Bathymodiolus Mussels JI Miyazaki, LO Martins, Y Fujita, H Matsumoto, Y Fujiwara PLoS one 5 (4), e10363, 2010 | 101 | 2010 |
| Genomic reconstruction of the SARS-CoV-2 epidemic in England HS Vöhringer, T Sanderson, M Sinnott, N De Maio, T Nguyen, R Goater, ... Nature 600 (7889), 506-511, 2021 | 97 | 2021 |
| CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes DJ Baker, A Aydin, T Le-Viet, GL Kay, S Rudder, L de Oliveira Martins, ... Genome medicine 13, 1-11, 2021 | 96 | 2021 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 75 | 2021 |
| COVID-19 due to the B. 1.617. 2 (Delta) variant compared to B. 1.1. 7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study K Kläser, E Molteni, M Graham, LS Canas, MF Österdahl, M Antonelli, ... Scientific reports 12 (1), 10904, 2022 | 59 | 2022 |
| Exposure of Salmonella biofilms to antibiotic concentrations rapidly selects resistance with collateral tradeoffs E Trampari, ER Holden, GJ Wickham, A Ravi, LO Martins, GM Savva, ... NPJ biofilms and microbiomes 7 (1), 3, 2021 | 59 | 2021 |
Andrew J. PageDirector of Technical Innovation, Theiagen Genomics確認したメール アドレス: quadram.ac.uk
